Mimedx (MDXG) EV to CFO (2011 - 2026)
Mimedx's (MDXG) quarterly EV to CFO came in at 42.46 in Q2 2026, down 177.99% year-over-year from 54.44 in Q2 2025, and down 118.62% quarter-over-quarter from 228.05 in Q1 2026.
Analysis
Mimedx (MDXG) EV to CFO (2011 - 2026) Analysis & Trends
Mimedx has disclosed EV to CFO across 16 years of filings, most recently posting 42.46 for Q2 2026.
- In Q2 2026, EV to CFO fell 177.99% year-over-year to 42.46; the TTM figure through Jun 2026 stood at 9.21 (down 31.78% YoY), while the FY2025 annual figure was 11.3, down 42.04% from the prior year.
- EV to CFO came in at 42.46 for Q2 2026 at Mimedx, down from 228.05 in the prior quarter.
- In the past five years, EV to CFO ranged from a high of 263.83 in Q3 2022 to a low of 107.06 in Q2 2022.
- Average EV to CFO over 5 years is 55.67, with a median of 42.64 recorded in 2023.
- Year-over-year, EV to CFO surged 327.9% in 2023 and tumbled 177.99% in 2026.
- Over 5 years, EV to CFO stood at 44.48 in 2022, then surged by 327.9% to 101.37 in 2023, then tumbled by 31.24% to 69.7 in 2024, then sank by 51.91% to 33.52 in 2025, then plunged by 226.67% to 42.46 in 2026.
- Per Business Quant data, the three most recent EV to CFO figures were 42.46 in Q2 2026, 228.05 in Q1 2026, and 33.52 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 126.56 Bn | 121.34 Bn | 1.96 Bn |
| 3 | Medtronic | 118.15 Bn | 109.33 Bn | 6.34 Bn |
| 4 | Stryker | 104.94 Bn | 101.46 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.87 Bn | 45.62 Bn | 1.35 Bn |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn |
| 8 | Dexcom | 32.07 Bn | 30.13 Bn | 830.00 Mn |
| 9 | Steris | 20.78 Bn | 20.29 Bn | 684.20 Mn |
| 10 | Mimedx | 676.17 Mn | 540.33 Mn | 44.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -42.46 |
| Mar 31, 2026 | 228.05 |
| Dec 31, 2025 | 33.52 |
| Sep 30, 2025 | 30.40 |
| Jun 30, 2025 | 54.44 |
| Mar 31, 2025 | 191.62 |
| Dec 31, 2024 | 69.70 |
| Sep 30, 2024 | 39.73 |
| Jun 30, 2024 | 43.21 |
| Mar 31, 2024 | 160.28 |
| Dec 31, 2023 | 101.37 |
| Sep 30, 2023 | 64.75 |
| Jun 30, 2023 | 42.06 |
| Mar 31, 2023 | -82.07 |
| Dec 31, 2022 | -44.48 |
| Sep 30, 2022 | 263.83 |
| Jun 30, 2022 | -107.06 |
| Mar 31, 2022 | -44.82 |
| Dec 31, 2021 | -52.94 |
| Sep 30, 2021 | 93.05 |